Structure |
Chemical Name |
CAS |
MF |
![Palbociclib-012](/CAS/20210111/GIF/2206135-30-8.gif) |
Palbociclib-012 |
2206135-30-8 |
C41H55N11O5 |
![Tigecycline Impurity E](/) |
Tigecycline Impurity E |
|
|
![Cefminox Impurity B](/) |
Cefminox Impurity B |
|
|
![isopropyl 4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl) benzenesulfonate](/CAS/20200119/GIF/CB34928367.gif) |
isopropyl 4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl) benzenesulfonate |
|
C20H19F3N2O3S |
![N-(2-ヒドロキシエチル)-4-ピリジンカルボアミド](/CAS/GIF/6265-74-3.gif) |
N-(2-ヒドロキシエチル)-4-ピリジンカルボアミド |
6265-74-3 |
C8H10N2O2 |
![BENAZEPRIL RELATED COMPOUND G ((3-(1-エトキシカルボニル-3-フェニル-(1S)-プロピル)アミノ-2,3,4,5-テトラヒドロ-2-オキソ-1H-1-(3S)-ベンズアゼピン)-1-酢酸, エチルエステル)](/CAS/20150408/GIF/103129-58-4.gif) |
BENAZEPRIL RELATED COMPOUND G ((3-(1-エトキシカルボニル-3-フェニル-(1S)-プロピル)アミノ-2,3,4,5-テトラヒドロ-2-オキソ-1H-1-(3S)-ベンズアゼピン)-1-酢酸, エチルエステル) |
103129-58-4 |
C26H32N2O5 |
![CLOPIDOGREL RELATED COMPOUND C (メチル(-)-(R)-(O-クロロフェニル)-6,7-ジヒドロチエノ[3,2-C]ピリジン-5(4H)-アセタート, 硫酸水素塩)](/CAS/GIF/120202-71-3.gif) |
CLOPIDOGREL RELATED COMPOUND C (メチル(-)-(R)-(O-クロロフェニル)-6,7-ジヒドロチエノ[3,2-C]ピリジン-5(4H)-アセタート, 硫酸水素塩) |
120202-71-3 |
C16H18ClNO6S2 |
![2-(3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-2-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile](/CAS/20200119/GIF/CB35170758.gif) |
2-(3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-2-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile |
|
C16H17N7O2S |
![Ipragliflozin Impurity 4](/) |
Ipragliflozin Impurity 4 |
|
|
![Mupirocin iMpurity 6](/CAS/20200119/GIF/CB35417655.gif) |
Mupirocin iMpurity 6 |
|
C26H44O9 |
![Vitamin B1 Impurity 5](/CAS/20200119/GIF/2443-50-7.gif) |
Vitamin B1 Impurity 5 |
2443-50-7 |
C12H17ClN4OS |
![Irbesartan IMpurity 16](/CAS/20200119/GIF/CB35423100.gif) |
Irbesartan IMpurity 16 |
|
C25H28N6O |
![479348-49-7](/CAS/20211123/GIF/479348-49-7.gif) |
479348-49-7 |
479348-49-7 |
C20H19FN2O6 |
![295366-48-2](/CAS/20211123/GIF/295366-48-2.gif) |
295366-48-2 |
295366-48-2 |
C17H25NO3 |
![(3S,4R)-phenyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-phenyl piperidine-1-carboxylate](/CAS/20200119/GIF/CB35429238.gif) |
(3S,4R)-phenyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-phenyl piperidine-1-carboxylate |
|
C26H25NO5 |
![Fluticasone Impurity 13](/CAS/20200119/GIF/CB35430405.gif) |
Fluticasone Impurity 13 |
|
C25H31F3O5S |
![nicergoline impurity K](/) |
nicergoline impurity K |
|
|
![Clopidogrel Impurity 46](/CAS/20200119/GIF/1801260-21-8.gif) |
Clopidogrel Impurity 46 |
1801260-21-8 |
C25H26ClNO6S |
![Rosuvastatin Impurity 89](/CAS/20210111/GIF/2226413-61-0.gif) |
Rosuvastatin Impurity 89 |
2226413-61-0 |
C38H46F2N6O9S2 |
![Ibuprofen EP Impurity I](/CAS/20200119/GIF/CB35433734.gif) |
Ibuprofen EP Impurity I |
2143535-26-4 |
C13H18O2 |
![Moxifloxacin Impurity 11](/) |
Moxifloxacin Impurity 11 |
|
|
![Linagliptin Impurity 7](/CAS/20210305/GIF/2416949-69-2.gif) |
Linagliptin Impurity 7 |
2416949-69-2 |
C25H29N7O4 |
![Tofacitinib Related Compound 16](/CAS/20210111/GIF/2183519-70-0.gif) |
Tofacitinib Related Compound 16 |
2183519-70-0 |
C15H23N5 |
![Vortioxetine Impurity 8](/) |
Vortioxetine Impurity 8 |
|
|
![Erlotinib Impurity 21](/) |
Erlotinib Impurity 21 |
|
|
![Fluvastatin EP Impurity C](/CAS/20200119/GIF/CB35434029.gif) |
Fluvastatin EP Impurity C |
779995-42-5 |
C24H26FNO4 |
![Oseltamivir Impurity 17](/CAS/20210111/GIF/2413185-88-1.gif) |
Oseltamivir Impurity 17 |
2413185-88-1 |
C14H22O4 |
![Topiroxostat Impurity 15](/) |
Topiroxostat Impurity 15 |
|
|
![Teneligliptin Impurity 10 Di-Trifluoroacetate](/) |
Teneligliptin Impurity 10 Di-Trifluoroacetate |
|
|
![Posaconazole iMpurity 68](/) |
Posaconazole iMpurity 68 |
|
|
![Erlotinib Hydrochloride iMpurity 50](/) |
Erlotinib Hydrochloride iMpurity 50 |
|
|
![(S)-methyl 9,10-difluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino [2,3,4-ij]quinoline-6-carboxylate](/CAS/20200119/GIF/1213269-49-8.gif) |
(S)-methyl 9,10-difluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino [2,3,4-ij]quinoline-6-carboxylate |
1213269-49-8 |
C14H11F2NO4 |
![Vonoprazan Impurity U3](/) |
Vonoprazan Impurity U3 |
|
|
![Prucalopride Impurity 10/ethyl 4-(4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxamido)piperidine-1-carboxylate](/CAS/20210111/GIF/137211-63-3.gif) |
Prucalopride Impurity 10/ethyl 4-(4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxamido)piperidine-1-carboxylate |
137211-63-3 |
C17H22ClN3O4 |
![Cefonicid Impurity 1](/) |
Cefonicid Impurity 1 |
|
|
![1589503-93-4](/CAS/20200611/GIF/1589503-93-4.gif) |
1589503-93-4 |
1589503-93-4 |
C27H24F2N6O3S |
![Androstane-3,17-diol,2-(4-morpholinyl)-16-(1-pyrrolidinyl)](/CAS/GIF/119302-22-6.gif) |
Androstane-3,17-diol,2-(4-morpholinyl)-16-(1-pyrrolidinyl) |
119302-22-6 |
C31H50N2O5 |
![Landiolol impurity W](/) |
Landiolol impurity W |
|
|
![Metoprolol IMpurity T](/CAS/20200119/GIF/CB35477431.gif) |
Metoprolol IMpurity T |
|
C15H25NO3 |
![Teneligliptin Impurity 11](/CAS/20211123/GIF/2131105-24-1.gif) |
Teneligliptin Impurity 11 |
2131105-24-1 |
C25H35N5O4 |
![Teneligliptin Impurity 16](/) |
Teneligliptin Impurity 16 |
|
|
![IMP-EP-M](/CAS/20210111/GIF/1193104-80-1.gif) |
IMP-EP-M |
1193104-80-1 |
C60H79N2O15S+ |
![Hyoscine Butylbromide EP Impurity H](/) |
Hyoscine Butylbromide EP Impurity H |
|
|
![Androstane-2,17-diol, 3-(4-morpholinyl)-16-(1-pyrrolidinyl)-, (2α,3β,5α,16β,17β)-](/CAS/20211123/GIF/1252016-49-1.gif) |
Androstane-2,17-diol, 3-(4-morpholinyl)-16-(1-pyrrolidinyl)-, (2α,3β,5α,16β,17β)- |
1252016-49-1 |
C27H46N2O3 |
![(S)-N,N-dimethyl-3-((R)-3-(naphthalen-1-yloxy)-1-phenylpropoxy)-1-phenylpropan-1-amine](/CAS/20200119/GIF/CB35519890.gif) |
(S)-N,N-dimethyl-3-((R)-3-(naphthalen-1-yloxy)-1-phenylpropoxy)-1-phenylpropan-1-amine |
|
C30H33NO2 |
![ETHYL 4-CHLORO-2-HYDROXYIMINO-3-OXO-BUTYRATE](/CAS/20200515/GIF/66338-95-2.gif) |
ETHYL 4-CHLORO-2-HYDROXYIMINO-3-OXO-BUTYRATE |
66338-95-2 |
C6H8ClNO4 |
![2-((R)-3-(diisopropylamino)-1-phenylpropyl)-4-(1-hydroxyethyl)phenyl isobutyrate](/CAS/20200119/GIF/CB35559690.gif) |
2-((R)-3-(diisopropylamino)-1-phenylpropyl)-4-(1-hydroxyethyl)phenyl isobutyrate |
|
C27H39NO3 |
![NA](/) |
NA |
|
|
![Palbociclib impurity LAAP](/) |
Palbociclib impurity LAAP |
|
|
![(R)-N-((S)-1-amino-1-oxobutan-2-yl)-3-((((S)-1-amino-1-oxobutan-2-yl)amino)methyl)hexanamide](/CAS/20200119/GIF/CB35559993.gif) |
(R)-N-((S)-1-amino-1-oxobutan-2-yl)-3-((((S)-1-amino-1-oxobutan-2-yl)amino)methyl)hexanamide |
|
C15H30N4O3 |
![Dapagliflozin Impurity 32](/CAS/20211123/GIF/1528636-07-8.gif) |
Dapagliflozin Impurity 32 |
1528636-07-8 |
C22H27ClO7 |
![1,1'-(1,4-phenylenebis(methylene))bis(1,4,8,11-tetraazacyclotetradecane 1-oxide)](/CAS/20200119/GIF/CB35574570.gif) |
1,1'-(1,4-phenylenebis(methylene))bis(1,4,8,11-tetraazacyclotetradecane 1-oxide) |
|
C28H54N8O2 |
![N-(2-amino-6-oxo-3,6-dihydropyrimidin-4-yl)-](/) |
N-(2-amino-6-oxo-3,6-dihydropyrimidin-4-yl)- |
|
|
![Droxidopa Impurity 6](/CAS/20200515/GIF/90044-46-5.gif) |
Droxidopa Impurity 6 |
90044-46-5 |
C16H15NO4 |
![Dofetilide Impurity B](/) |
Dofetilide Impurity B |
|
|
![Cyclic Macitentan quarternary salt Impurity](/) |
Cyclic Macitentan quarternary salt Impurity |
|
|
![Cefdinir CP Impurity I&J&K&L](/) |
Cefdinir CP Impurity I&J&K&L |
|
|
![Dapoxetine Impurity 41](/) |
Dapoxetine Impurity 41 |
|
|
![Doxofylline Impurity 16](/) |
Doxofylline Impurity 16 |
|
|
![Olopatadine Impurity 5](/) |
Olopatadine Impurity 5 |
55690-18-1 |
C17H16O5 |
![Taladafil Impurity 38](/) |
Taladafil Impurity 38 |
|
|
![Gadobutrol Impurity 20](/) |
Gadobutrol Impurity 20 |
|
|
![Dapagliflozin Impurity 48](/CAS/20200611/GIF/2069934-29-6.gif) |
Dapagliflozin Impurity 48 |
2069934-29-6 |
C15H14Cl2O |
![Cilostazol Impurity I](/) |
Cilostazol Impurity I |
|
|
![Pramipexole DBTA Impurity](/CAS/20200611/GIF/1821389-09-6.gif) |
Pramipexole DBTA Impurity |
1821389-09-6 |
C7H8N2S |
![TERBUTALINE IMPURITY C](/CAS/20210111/GIF/139508-58-0.gif) |
TERBUTALINE IMPURITY C |
139508-58-0 |
C12H17NO3 |
![ZIDOVUDINE IMPURITY B](/) |
ZIDOVUDINE IMPURITY B |
|
|
![Acetamide, N-[2-hydroxy-3-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]propyl]-N-(1-methylethyl)-](/CAS/20200515/GIF/66722-65-4.gif) |
Acetamide, N-[2-hydroxy-3-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]propyl]-N-(1-methylethyl)- |
66722-65-4 |
C20H33NO5 |
![Pyrimidine, 4-bromo-6-(1-bromoethyl)-5-fluoro-](/CAS/20200515/GIF/1307315-02-1.gif) |
Pyrimidine, 4-bromo-6-(1-bromoethyl)-5-fluoro- |
1307315-02-1 |
C6H5Br2FN2 |
![4-(3,4-dichlorophenyl)-N-methyl-3,4-dihydro-2H-naphthalen-1-imine oxide](/CAS/20210111/GIF/209473-00-7.gif) |
4-(3,4-dichlorophenyl)-N-methyl-3,4-dihydro-2H-naphthalen-1-imine oxide |
209473-00-7 |
C17H15Cl2NO |
![Tazobactam Impurity EBT](/) |
Tazobactam Impurity EBT |
|
|
![Mixture of Cefoxitin Impurities E&F](/) |
Mixture of Cefoxitin Impurities E&F |
|
|
![Faropenem Degradation Impurity 4](/) |
Faropenem Degradation Impurity 4 |
|
|
![7-(2-hydroxy-1,1-dimethoxypropyl)-5H-chromeno[2,3-b]pyridin-5-ol](/) |
7-(2-hydroxy-1,1-dimethoxypropyl)-5H-chromeno[2,3-b]pyridin-5-ol |
|
|
![2-chloro-1-(5-methoxy-5H-chromeno[2,3-b]pyridin-7-yl)propan-1-one](/) |
2-chloro-1-(5-methoxy-5H-chromeno[2,3-b]pyridin-7-yl)propan-1-one |
|
|
![Oxacillin Impurity 3](/CAS/20210111/GIF/21106-64-9.gif) |
Oxacillin Impurity 3 |
21106-64-9 |
C19H18ClN3O5S |
![Latanoprost Impurity 3](/CAS/20210111/GIF/2278245-92-2.gif) |
Latanoprost Impurity 3 |
2278245-92-2 |
C27H41BrO5 |
![Ethyl 2-(2-Iodoethoxy)acetate](/CAS/20210111/GIF/56703-25-4.gif) |
Ethyl 2-(2-Iodoethoxy)acetate |
56703-25-4 |
C6H11IO3 |
![Butyphthalide impurity 53](/) |
Butyphthalide impurity 53 |
|
|
![6,8-DIBROMO-3-CYCLOHEXYL-3,4-DIHYDRO-2(1H)-QUINAZOLINONE](/StructureFile/ChemBookStructure22/GIF/CB3646645.gif) |
6,8-DIBROMO-3-CYCLOHEXYL-3,4-DIHYDRO-2(1H)-QUINAZOLINONE |
21237-84-3 |
C14H16Br2N2O |
![DESTHIAZOLYLMETHYL RITONAVIR](/CAS/20150408/GIF/256328-82-2.gif) |
DESTHIAZOLYLMETHYL RITONAVIR |
256328-82-2 |
C33H43N5O4S |
![S-DIDEMETHYL CITALOPRAM](/CAS/20180808/GIF/166037-78-1.gif) |
S-DIDEMETHYL CITALOPRAM |
166037-78-1 |
C18H17FN2O |
![メトトレキサートジメチルエステル](/CAS/GIF/34378-65-9.gif) |
メトトレキサートジメチルエステル |
34378-65-9 |
C22H26N8O5 |
![1-イソプロピル-3-(4-フルオロフェニル)-1H-インドール-2-カルボアルデヒド](/CAS/GIF/101125-34-2.gif) |
1-イソプロピル-3-(4-フルオロフェニル)-1H-インドール-2-カルボアルデヒド |
101125-34-2 |
C18H16FNO |
![3,4-ジメトキシサリチルアルデヒド](/CAS/GIF/19283-70-6.gif) |
3,4-ジメトキシサリチルアルデヒド |
19283-70-6 |
C9H10O4 |
![Sugammadex sodium Org199129-1 Impurity](/) |
Sugammadex sodium Org199129-1 Impurity |
|
|
![Sugammadex sodium Impurity 41](/) |
Sugammadex sodium Impurity 41 |
|
|
![4-(5-methyl-2-phenyloxazol-4-yl)benzenesulfonamide](/CAS/20210111/GIF/2242749-01-3.gif) |
4-(5-methyl-2-phenyloxazol-4-yl)benzenesulfonamide |
2242749-01-3 |
C16H14N2O3S |
![Cefazolin Impurity EP-I](/) |
Cefazolin Impurity EP-I |
|
|
![Cabozantinib impurity 42](/) |
Cabozantinib impurity 42 |
|
|
![Cabozantinib impurity 55](/) |
Cabozantinib impurity 55 |
|
|
![Canagliflozin Impurity 68](/) |
Canagliflozin Impurity 68 |
|
|
![Dapoxetine impurity 51](/) |
Dapoxetine impurity 51 |
|
|
![Doxofylline Impurity 20](/) |
Doxofylline Impurity 20 |
|
|
![Dapoxetine impurity 64](/) |
Dapoxetine impurity 64 |
|
|
![Dapoxetine impurity 58](/) |
Dapoxetine impurity 58 |
|
|
![Peramivir Impurity 23](/) |
Peramivir Impurity 23 |
|
|
![Silodosin Carboxylic Acid Impurity](/CAS/20210111/GIF/1431373-77-1.gif) |
Silodosin Carboxylic Acid Impurity |
1431373-77-1 |
C25H31F3N2O5 |
![Pramipexole Impurity M](/) |
Pramipexole Impurity M |
|
|
![Premastast Impurity 2](/) |
Premastast Impurity 2 |
|
|